KELLY HEARD: Open Payments
NPI 1689020265 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 29 payments from 10 companies in 2025. Trend: 2023 $298 · 2024 $597 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 7 | $245 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $121 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| GENZYME CORPORATION | 3 | $94 |
| Regeneron Healthcare Solutions, Inc. | 2 | $58 |
| ABBVIE INC. | 1 | $23 |
| Boston Scientific Corporation | 1 | $21 |
| ALK-Abello, Inc | 1 | $21 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $19 |
| Preceptis Medical, Inc. | 1 | $16 |
Products named: INSPIRE, DUPIXENT, XIFAXAN, NUCALA, MAVYRET, WATCHMAN FLX, Odactra, NEFFY.
Industry payments across GA — which companies pay providers there.
